In July, the U.S. Food and Drug Administration (FDA) issued a request for comments associated with a Part 15 public hearing it hosted on the topic of psychedelics. (See No Questions Asked: FDA’s Psychedelics Public Hearing.) That docket was open through October 5th, though it has taken some time for comments to be posted to Regulations.gov. At the time of writing, however, all comments appear to…
